Piretanide

Piretanide Structure
Piretanide structure
Common Name Piretanide
CAS Number 55837-27-9 Molecular Weight 362.40000
Density 1.415 g/cm3 Boiling Point 597.7ºC at 760 mmHg
Molecular Formula C17H18N2O5S Melting Point 225-227°C (lit.)
MSDS N/A Flash Point 315.3ºC

Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries.

Br. J. Pharmacol. 131(6) , 1211-9, (2000)

1. Relaxing effect of loop diuretics, piretanide and furosemide in comparison with acetylcholine (ACh) was investigated in guinea-pig isolated mesenteric resistance arteries. 2. Concentration-response curves to ACh (0.001 - 10 microM) and diuretics (0.0001 - ...

Modulation of chloride, potassium and bicarbonate transport by muscarinic receptors in a human adenocarcinoma cell line.

Br. J. Pharmacol. 126(1) , 269-79, (1999)

1. Short-circuit current (I(SC)) responses to carbachol (CCh) were investigated in Colony 1 epithelia, a subpopulation of the HCA-7 adenocarcinoma cell line. In Krebs-Henseleit (KH) buffer, CCh responses consisted of three I(SC) components: an unusual rapid d...

Fc epsilon RI-mediated chloride uptake by rat mast cells: modulation by chloride transport inhibitors in relation to histamine secretion.

Br. J. Pharmacol. 122(6) , 1188-94, (1997)

1. We have examined the role of extracellular chloride in the mast cell secretion process. The immunologically-directed ligand, antibody to IgE (anti-IgE) required extracellular chloride ions for optimum secretion from rat peritoneal mast cells. In contrast, ...

Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.

Am. J. Cardiol. 72(9) , 666-71, (1993)

To test the dose responses of piretanide, ramipril, and their combination in patients with essential hypertension, a prospective, randomized, double-blind, placebo-controlled trial was conducted in 480 patients. Twelve separate groups were studied: placebo, p...

Increased (Na+K+Cl) cotransport in rat arterial smooth muscle in deoxycorticosterone (DOCA)/salt-induced hypertension.

J. Vasc. Res. 36(6) , 492-501, (1999)

The inhibition by loop diuretics of K efflux (tracer (86)Rb) from the rat femoral arterial smooth muscle was measured in normotension and in DOCA-salt hypertension. The sensitivity sequence (bumetanide > piretanide > furosemide) was the characteristic pharmac...

Stability-indicating methods for the determination of piretanide in presence of the alkaline induced degradates.

J. Pharm. Biomed. Anal. 39(5) , 871-6, (2005)

Stability-indicating high performance liquid chromatography (HPLC), thin-layer chromatography (TLC) and first-derivative of ratio spectra (1DD) methods are developed for the determination of piretanide in presence of its alkaline induced degradates. HPLC meth...

Pharmacokinetics and pharmacodynamics of ramipril and piretanide administered alone and in combination.

Eur. J. Clin. Pharmacol. 46(6) , 545-50, (1994)

The pharmacokinetics and pharmacodynamics of single oral doses of 5 mg ramipril and 6 mg piretanide administered separately and in combination were determined in a single blind, randomised, 3-period cross-over study in 24 healthy male volunteers. The peak pla...

Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.

Pharmacotherapy 4(4) , 170-80, (1984)

Piretanide is a high-ceiling, loop-active diuretic that has been developed for treatment of congestive heart failure, hypertension and edematous states caused by renal and hepatic diseases. Piretanide is structurally related to furosemide and bumetanide; when...

Effect of Na/K/2Cl transporter inhibition with piretanide on postischemic kidney function.

Transplant. Proc. 28(1) , 83-4, (1996)

[Profile of the action of diuretics. Piretanide in comparison with thiazides and anti-kaliuretic drugs].

Internist (Berl.) 33 Suppl 1 , S16-22, (1992)